Abstract Number: 9 • ACR/ARP Annual Meeting 2019
Chemokine CXCL 10 Gene Expression as a Potential Activity Biomarker of Systemic Lupus Erythematosus
Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by a wide range of systemic dysfunctions as well as an elevated erythrocyte sedimentation rate. Chemokine CXCL 10…Abstract Number: 1702 • ACR/ARHP Annual Meeting 2018
Utility of the Avise Connective Tissue Disease Test in Predicting Lupus Diagnosis and Progression of Disease
Background/Purpose: The AVISE Connective Tissue Disease test is a newly approved, commercially available test that combines autoantibody and biomarker levels to help diagnose systemic lupus…Abstract Number: 2344 • ACR/ARHP Annual Meeting 2017
Cell-Bound Complement Activation Products As Markers of Disease Flares in Childhood Onset Systemic Lupus Erythematosus
Background/Purpose: Cell-bound complement activation products, CB-CAPs (C4d deposition on erythrocytes [EC4d], B lymphocytes [BC4d], reticulocytes [RC4d], platelets [PC4d], and C3d deposition on reticulocytes [RC3d]) are…Abstract Number: 756 • ACR/ARHP Annual Meeting 2015
Axl, Ferritin, IGFBP2 and TNFR2 As Biomarkers in Systemic Lupus Erythematosus
Background/Purpose: To evaluate the performance of 4 novel serum protein markers for detecting concurrent disease activity in systemic lupus erythematosus (SLE). Methods: Consecutive patients who…
